One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Do PCI Facility Openings and Closures Affect AMI Outcomes Differently in High- vs Average-Capacity Markets?
Yu-Chu Shen, PHD, a,b Harlan M. Krumholz, MD, SM, c,d,e Renee Y. Hsia, MD, MS C
doi : 10.1016/j.jcin.2023.02.010
Volume 16, Issue 10, 22 May 2023, Pages 1129-1140
Disparities in access to percutaneous coronary intervention (PCI) for patients with acute myocardial infarction may result from openings and closures of PCI-providing hospitals, potentially leading to low hospital PCI volume, which is associated with poor outcomes.
PCI Facility Openings and Closures: If You Build It, Will They Benefit?∗
Steven R. Bailey, MD
doi : 10.1016/j.jcin.2023.03.037
Volume 16, Issue 10, 22 May 2023, Pages 1141-1143
Effects of Elective Coronary Revascularization vs Medical Therapy Alone on Noncardiac Mortality: A Meta-Analysis
Eliano P. Navarese, MD, P HD, a,b,c Alexandra J. Lansky, MD, d Michael E. Farkouh, MD, MS C,e,f Klaudyna Grzelakowska, MD,a,c Marc P. Bonaca, MD, g Diana A. Gorog, MD, PHD, h,i Paolo Raggi, MD, b Malte Kelm, MD, j,k Brandon Yeo, MS, a,c Julia Uminska, MD, PH D, a,c Nick Curzen, BM(H ONS), P HD, l,m Jacek Kubica, MD, P HD, a,c William Wijns, MD, PHD, n Dean J. Kereiakes, MD
doi : 10.1016/j.jcin.2023.02.030
Volume 16, Issue 10, 22 May 2023, Pages 1144-1156
Uncertainty exists whether coronary revascularization plus medical therapy (MT) is associated with an increase in noncardiac mortality in chronic coronary syndrome (CCS) when compared with MT alone, particularly following recent data from the ISCHEMIA-EXTEND (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial.
Does it Matter What the Cause of Death Is in Revascularization Trials?∗
Harvey D. White, MB CH B, DS C
doi : 10.1016/j.jcin.2023.03.042
Volume 16, Issue 10, 22 May 2023, Pages 1157-1159
Ventricular Remodeling and Outcomes After Mitral Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial
Brian R. Lindman, MD, MSC ,a Federico M. Asch, MD, b Paul A. Grayburn, MD,c Michael J. Mack, MD,d Jeroen J. Bax, MD, PHD, e Holly Gonzales, MD,a Kashish Goel, MD, a Colin M. Barker, MD,a Sandip K. Zalawadiya, MBBS, a Zhipeng Zhou, MA, f Maria C. Alu, MS, f Neil J. Weissman, MD,b William T. Abraham, MD,g JoAnn Lindenfeld, MD,a Gregg W. Stone, MD
doi : 10.1016/j.jcin.2023.02.031
Volume 16, Issue 10, 22 May 2023, Pages 1160-1172
The relationship between left ventricular (LV) remodeling and clinical outcomes after treatment of severe mitral regurgitation (MR) in heart failure (HF) has not been examined.
Paradoxes Continued: Treatment of Secondary MR and Impact on Ventricular Remodeling∗
Felix Kreidel, MD,a Derk Frank, MD,a Philipp Bartko, MD, PHD
doi : 10.1016/j.jcin.2023.03.052
Volume 16, Issue 10, 22 May 2023, Pages 1173-1175
Impact of Mitral Regurgitation Etiology on Mitral Surgery After Transcatheter Edge-to-Edge Repair: From the CUTTING-EDGE Registry
Syed Zaid, MD, a, * Marisa Avvedimento, MD,b, * Keti Vitanova, MD, c Serdar Akansel, MD,d Oliver D. Bhadra, MD, e Guido Ascione, MD, f Shekhar Saha, MD, g Thilo Noack, MD, h Ana Paula Tagliari, MD, P HD, i Alejandro Pizano, MD, M SBME, j Marissa Donatelle, MD, k John J. Squiers, MD,l Kashish Goel, MD,m Guillaume Leurent, MD, n Anita W. Asgar, MD, o Chawannuch Ruaengsri, MD, p Lin Wang, MD,q Lionel Leroux, MD, r Michele Flagiello, MD,s Muhanad Algadheeb, MD, t Paul Werner, MD, u Angie Ghattas, MD, v Antonio L. Bartorelli, MD,w Nicholas Dumonteil, MD, v Arnar Geirsson, MD,x Eric Van Belle, MD, PHD, y Francesco Massi, MD,z Moritz Wyler von Ballmoos, MD, PHD, MPH,aa Sachin S. Goel, MD, a Michael J. Reardon, MD, a Vinayak N. Bapat, MD,bb Tamim M. Nazif, MD, cc Tsuyoshi Kaneko, MD,dd Thomas Modine, MD, PH D, MBA, r Paolo Denti, MD, f Gilbert H.L. Tang, MD, MS C, MBA,
doi : 10.1016/j.jcin.2023.02.029
Volume 16, Issue 10, 22 May 2023, Pages 1176-1188
Can Transcatheter Edge-to-Edge Mitral Repair Be Considered as Efficient as Surgical Mitral Valve Repair?∗
Gilles D. Dreyfus, MD, PHD, a Benjamin Essayagh, MD
doi : 10.1016/j.jcin.2023.04.034
Volume 16, Issue 10, 22 May 2023, Pages 1189-1191
Impact of High Implantation of Transcatheter Aortic Valve on Subsequent Conduction Disturbances and Coronary Access
Tomoki Ochiai, MD, a Futoshi Yamanaka, MD,a Koki Shishido, MD,a Noriaki Moriyama, MD,a Ikki Komatsu, MD, b Hiroaki Yokoyama, MD,a Hirokazu Miyashita, MD,a Daisuke Sato, MD,a Yoichi Sugiyama, MD,a Takahiro Hayashi, MD,a Takayoshi Yamashita, MD, a Kazuki Tobita, MD,a Takashi Matsumoto, MD,a Shingo Mizuno, MD,a Yutaka Tanaka, MD, a Masato Murakami, MD,a Saeko Takahashi, MD,a Raj Makkar, MD,c Shigeru Saito, MD
doi : 10.1016/j.jcin.2023.03.021
Volume 16, Issue 10, 22 May 2023, Pages 1192-1204
Data regarding the impact of high transcatheter heart valve (THV) implantation on coronary access after transcatheter aortic valve replacement (TAVR) as assessed by postimplantation computed tomography (CT) are scarce.
TAVR Roulette: Go High or Go Low∗
Darren Mylotte, MB, MD, PHD, a Simone Fezzi, MD, MS C
doi : 10.1016/j.jcin.2023.04.021
Volume 16, Issue 10, 22 May 2023, Pages 1205-1207
Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry
Soledad Ojeda, MD, PHD,a,b,c, * Rafael Gonz?lez-Manzanares, MD, PHD,a,b, * Pilar Jiménez-Quevedo, MD, PHD,d,e Pablo Pi??n, MD,f Lluis Asmarats, MD, PHD,g Ignacio Amat-Santos, MD, PHD,h,i Eduard Fern?ndez-Nofrerias, MD,j Raquel del Valle, MD,k Erika Mu?oz-Garc?a, MD,i,l Maria-Cruz Ferrer-Gracia, MD, PHD,m Jose Mar?a de la Torre, MD, PHD,n,o Valeriano Ruiz-Quevedo, MD,p Ander Regueiro, MD, PHD,q Dario Sanmiguel, MD,r Sergio Garc?a-Blas, MD, PHD,i,s,t Jaime El?zaga, MD, PHD,u,v Jose Antonio Baz, MD,w Rafael Romaguera, MD, PHD,x,y Ignacio Cruz-Gonz?lez, MD, PHD,i,z,aa José Moreu, MD,bb Livia L. Gheorghe, MD, PHD,cc Luisa Salido, MD, PHD,dd Ra?l Moreno, MD, PHD,ee,ff Crist?bal Urbano, MD,gg Vicenc Serra, MD,hh Manuel Pan, MD, PHD
doi : 10.1016/j.jcin.2023.03.024
Volume 16, Issue 10, 22 May 2023, Pages 1208-1217
Coronary obstruction (CO) following transcatheter aortic valve replacement (TAVR) is a life-threatening complication, scarcely studied.
Coronary Obstruction in TAVR: (Not) Knowing Your Enemy∗
Ariel Finkelstein, MD, Jeremy Ben-Shoshan, MD, P HD
doi : 10.1016/j.jcin.2023.04.020
Volume 16, Issue 10, 22 May 2023, Pages 1218-1220
Myocardial Injury After Transcatheter Aortic Valve Replacement According to VARC-3 Criteria
Carlos Real, MD, a,b Marisa Avvedimento, MD, a,c Jorge Nuche, MD, P HD, a Anna Franzone, MD, PH D, c Julio Farjat-Pasos, MD,a Kim-Hoang Trinh, MS, a Robert Delarochellière, MD, a Jean-Michel Paradis, MD, a Anthony Poulin, MD,a Eric Dumont, MD,a Dimitri Kalavrouziotis, MD,a Siamak Mohammadi, MD,a Siddartha Mengi, MD, a Giovanni Esposito, MD, PHD, c Josep Rodés-Cabau, MD, P HD
doi : 10.1016/j.jcin.2023.03.022
Volume 16, Issue 10, 22 May 2023, Pages 1221-1232
The Valve Academic Research Consortium (VARC)-3 definition for myocardial injury after transcatheter aortic valve replacement (TAVR) lacks of clinical validation.
VARC-3 Criteria: Adding Prognosis to Injury∗
Paul Guedeney, MD, Gabriel Chevrot, MD, Jean-Philippe Collet, MD, P HD
doi : 10.1016/j.jcin.2023.04.012
Volume 16, Issue 10, 22 May 2023, Pages 1233-1235
Occupational Safety in the Cardiac Catheterization Laboratory: Time for Better Ergonomics
Ahmed Hassanin, MD, MPH,a Karim Al-Azizi, MD, b Barry F. Uretsky, MD
doi : 10.1016/j.jcin.2023.02.036
Volume 16, Issue 10, 22 May 2023, Pages 1236-1238
2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee
doi : 10.1016/j.jcin.2023.04.011
Volume 16, Issue 10, 22 May 2023, Pages 1239-1291
Direct Transcatheter Mitral Valve-in-Ring Replacement to Treat a Failing Alfieri Valve Repair
Gaspard Suc, MD, a,b,c Dominique Himbert, MD,a,b Eric Brochet, MD,a Gregory Ducrocq, MD, P HD, a,b,c Alec Vahanian, MD,a,b,c Marina Urena, MD, PHD a,b,c
doi : 10.1016/j.jcin.2023.03.011
Volume 16, Issue 10, 22 May 2023, Pages 1292-1294
Percutaneous Transseptal Drainage of a Peri-Aortic Abscess Complicating Aortic Bioprosthetic Valve Infective Endocarditis
Goyal Umadat, MD, Samantha Espinosa, MD, Pragnesh Parikh, MD, Jordan Ray, MD, Peter Pollak, MD, Abdallah El Sabbagh, MD
doi : 10.1016/j.jcin.2023.03.010
Volume 16, Issue 10, 22 May 2023, Pages 1295-1296
Percutaneous Endovascular Repair of the Abdominal Aorta Iatrogenic Injury Using a Custom-Modified Fenestrated Stent Graft
Martina Maria Giambra, MD, a Flavia Iovino, MD,a Marco Barbanti, MD, b Matteo Cavallo, MD,a Carla Virgilio, MD, a Giuseppe Roscitano, MD,a Giuliano Costa, MD, b Pierfrancesco Veroux, MD
doi : 10.1016/j.jcin.2023.02.020
Volume 16, Issue 10, 22 May 2023, Pages 1297-1298
Percutaneous Recanalization of Interrupted Aortic Arch Using Laser Atherectomy
Cheuk Bong Ho, MBBS, Gintautas Bieliauskas, MD, Lars S?ndergaard, MD, DMS C, Michael Rahbek Schmidt, MD, PHD, DMS C
doi : 10.1016/j.jcin.2023.03.008
Volume 16, Issue 10, 22 May 2023, Pages 1299-1300
Percutaneous Retrieval of an Aortic Valve Vegetation Causing Severe Regurgitation and Cardiogenic Shock
Claudia Lama von Buchwald, MD,a Pedro Engel Gonzalez, MD,a Brian O’Neill, MD,a Dee Dee Wang, MD, a Tiberio Frisoli, MD, a William W. O’Neill, MD, b Pedro A. Villablanca, MD, MS C a
doi : 10.1016/j.jcin.2023.03.027
Volume 16, Issue 10, 22 May 2023, Pages 1301-1303
Optimized Pro Pathway: A Step in the Right Direction, But Not There Yet…
*Ashish Pershad, MD, MS
doi : 10.1016/j.jcin.2023.04.009
Volume 16, Issue 10, 22 May 2023, Page 1304
Can it Be Verified That Membranous Septum Length Does Not Impact New Permanent Pacemaker Implantation?
*Ying-Hwa Chen, MD, PhD
doi : 10.1016/j.jcin.2023.04.017
Volume 16, Issue 10, 22 May 2023, Page 1305
Reply: Optimized Pro Pathway—A Step in the Right Direction But Not There Yet. . . and the Use of the Membranous Septum Length in Evolut Implantation
Kendra J. Grubb, MD Steven Yakubov, MD
doi : 10.1016/j.jcin.2023.04.035
Volume 16, Issue 10, 22 May 2023, Pages 1306-1307
Lack of Exposure to Catheterization in Adults With CHD During IC Fellowship: Gap in IC Fellowship Curriculum?
Eduardo Flores-Umanzor, MD, PhD Rajesh Keshvara, MD Tahira Redwood, MD Mark Osten, MD Lee Benson, MD *Eric Horlick, MD
doi : 10.1016/j.jcin.2023.04.008
Volume 16, Issue 10, 22 May 2023, Page 1308
Reply: Lack of Exposure to Catheterization in Adults With CHD During IC Fellowship: Gap in IC Fellowship Curriculum?
Bahadir Simsek, MD *Emmanouil S. Brilakis, MD, PhD
doi : 10.1016/j.jcin.2023.04.016
Volume 16, Issue 10, 22 May 2023, Page 1309
Impact of a Dedicated Transseptal Transcatheter Mitral Valve Replacement System on Cardiac Remodeling and Hemodynamics
Augustin Coisne, MD, PhD Josep Rodés-Cabau, MD, PhD Sebastian Ludwig, MD Andrea Scotti, MD Jules Mesnier, MD Torsten P. Vahl, MD Lauren S. Ranard, MD Michael C. Evans, PhD Thomas Modine, MD, PhD Juan F. Granada, MD
doi : 10.1016/j.jcin.2023.02.037
Volume 16, Issue 10, 22 May 2023, Pages 1310-1312
3-Year Outcomes of Transcatheter Aortic Valve Replacement: Insights From the PORTICO I Registry
Francesco Maisano, MD Holger Thiele, MD Stephan Fichtlscherer, MD Dirk Westermann, MD Samer Hakmi, MD Joerg Kempfert, MD Francesco Bedogni, MD Gerald Yong, MD Nicholas Bates, PhD Lars S?ndergaard, MD
doi : 10.1016/j.jcin.2023.02.038
Volume 16, Issue 10, 22 May 2023, Pages 1313-1315
